Topical atorvastatin ameliorates 12-O-tetradecanoylphorbol-13-acetate induced skin inflammation by reducing cutaneous cytokine levels and NF-κB activation von Kulkarni, Nagaraj M, Muley, Milind M, Jaji, Mallikarjun S, Vijaykanth, G, Raghul, J, Reddy, Neetin Kumar D, Vishwakarma, Santosh L, Rajesh, Navin B, Mookkan, Jeyamurugan, Krishnan, Uma Maheswari, Narayanan, Shridhar

Volltext

A novel animal model of metabolic syndrome with non-alcoholic fatty liver disease and skin inflammation von Kulkarni, Nagaraj M., Jaji, Mallikarjun S., Shetty, Pranesha, Kurhe, Yeshwant V., Chaudhary, Shilpee, Vijaykant, G., Raghul, J., Vishwakarma, Santosh L., Rajesh, B. Navin, Mookkan, Jeyamurugan, Krishnan, Uma Maheswari, Narayanan, Shridhar

Volltext

Combination of vildagliptin and rosiglitazone ameliorates nonalcoholic fatty liver disease in C57BL/6 mice von Mookkan, Jeyamurugan, De, Soumita, Shetty, Pranesha, Kulkarni, Nagaraj, Devisingh, Vijayaraj, Jaji, Mallikarjun, Lakshmi, Vinitha, Chaudhary, Shilpee, Kulathingal, Jayanarayan, Rajesh, Navin, Narayanan, Shridhar

Volltext

Topical atorvastatin ameliorates 12-O-tetradecanoylphorbol-13- acetate induced skin inflammation by reducing cutaneous cytokine levels and NF-jB activation von Nagaraj M. Kulkarni, Milind M. Muley, Mallikarjun S. Jaji, G. Vijaykanth, J. Raghul, Neetin Kumar D. Reddy, Santosh L. Vishwakarma, Navin B. Rajesh, Jeyamurugan Mookkan, Uma Maheswari Krishnan, Shridhar Narayanan

Volltext